Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma

Sha-sha Wang; Xiao Cen; Xin-hua Liang; Ya-ling Tang

doi:10.18632/oncotarget.12890

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma

Sha-sha Wang _, Xiao Cen, Xin-hua Liang and Ya-ling Tang

PDF | HTML | How to cite

Oncotarget. 2017; 8:10650-10661. https://doi.org/10.18632/oncotarget.12890

Metrics: PDF 2526 views | HTML 2570 views | ?

Abstract

Sha-sha Wang1,2, Xiao Cen1,2, Xin-hua Liang1,2 and Ya-ling Tang1,3

1 State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu Sichuan, People’s Republic of China

2 Department of Oral and Maxillofacial Surgery, West China College of Stomatology, Sichuan University, Chengdu Sichuan, People’s Republic of China

3 Department of Oral Pathology, West China Hospital of Stomatology, Sichuan University, Chengdu Sichuan, People’s Republic of China

Correspondence to:

Xin-hua Liang, email:

Ya-ling Tang, email:

Keywords: macrophage migration inhibitory factor; head and neck squamous cell carcinoma; tumorigenesis; metastasis; biomarker

Received: September 20, 2016 Accepted: October 19, 2016 Published: October 25, 2016

Abstract

Macrophage migration inhibitory factor (MIF), a pleiotropic proinflammatory cytokine, has been showed to be associated with the immunopathogenesis of many diseases. Recent study demonstrated that MIF promoted tumorigenesis and tumor progression and played a critical role in various kinds of human cancer including head and neck squamous cell carcinoma(HNSCC). Hence, in this paper we retrospected the relationship between MIF and angiogenesis, epithelial-mesenchymal transition (EMT), inflammation, immune response, hypoxia microenvironment, and discussed whether it is a promising biomarker for diagnosis and supervisor of HNSCC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 12890

Publication Alerts

Reviews:

Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma

Abstract